Correlation between Carbonic Anhydrase Isozymes and the Evolution of Myocardial Infarction in Diabetic Patients
(1) Background: Myocardial infarction was, until recently, recognized as a major coronary event, often fatal, with major implications for survivors. According to some authors, diabetes mellitus is an important atherogenic risk factor with cardiac determinations underlying the definition of the so-ca...
Autores principales: | Sorina Magheru, Calin Magheru, Florin Maghiar, Liliana Sachelarie, Felicia Marc, Corina Maria Moldovan, Laura Romila, Anica Hoza, Dorina Maria Farcas, Irina Gradinaru, Loredana Liliana Hurjui |
---|---|
Formato: | Artículo |
Lenguaje: | English |
Publicado: |
MDPI AG
2022-08-01
|
Colección: | Biology |
Materias: | |
Acceso en línea: | https://www.mdpi.com/2079-7737/11/8/1189 |
Ejemplares similares
-
Evaluation of Hepatic Biochemical Parameters during Antiviral Treatment in COVID-19 Patients
por: Felicia Marc, et al.
Publicado: (2021-12-01) -
The effects of cardiac drugs on human erythrocyte carbonic anhydrase I and II isozymes
por: Onur Argan, et al.
Publicado: (2020-01-01) -
Development of a high throughput yeast-based screening assay for human carbonic anhydrase isozyme II inhibitors
por: Anyaporn Sangkaew, et al.
Publicado: (2018-08-01) -
Carbonic Anhydrase Type II Deficiency Syndrome
por: J Gordon Millichap
Publicado: (2012-01-01) -
Synthesis, characterization and in vitro inhibition of metal complexes of pyrazole based sulfonamide on human erythrocyte carbonic anhydrase isozymes I and II
por: Nurgün Büyükkıdan, et al.
Publicado: (2017-01-01)